Gene therapy and stem cells could treat Kidney Failure

March 2, 2019

Research has shown, in mice, that genetic material can be delivered to damaged cells in the kidneys, a key step toward developing gene therapy to treat chronic kidney disease. The potentially fatal condition affects 30 million Americans, most of whom don't realize they have chronic kidney disease.

Spotlight

Acceleron Pharma

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases.

OTHER VIDEOS

Pharmacy Management System Project in Python Source Code

video | May 21, 2022

Pharmacy Management System Project in Python Source Code What is Pharmacy Management System Project in Python...

Watch Now

AI accelerated drug discovery

video | May 20, 2022

AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of existing molecule, intelligent clinical design and coupled with in-house manufacturing....

Watch Now

Prescription Management System in SwilERP Pharmacy Software

video | May 27, 2022

Prescription Management is an essential task for the Pharmacist. The Prescription management feature of SwilERP Pharmacy Software enables the Pharmacists to create and maintain the medical records quickly and accurately evaluate the patient's health....

Watch Now

Accelerate Your Pharma 4.0 Journey with Our Manufacturing Execution Systems (MES) Solution

video | May 5, 2022

Today’s pharmaceutical manufacturers face increasing pressure to deliver high-quality medicines quickly, efficiently and economically while complying with regulatory requirements and meeting sustainability goals....

Watch Now

Spotlight

Acceleron Pharma

Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare diseases.

Events